about
Ceftriaxone-induced hemolysisReview of the use of cephalosporins in children with anaphylactic reactions from penicillinsThe current practice of skin testing for antibiotics in Korean hospitalsA statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross-reactivities.Anaphylaxis during the perioperative period.Adherence to perioperative antibiotic prophylaxis among orthopedic trauma patients.Diagnosis and management of immediate hypersensitivity reactions to cephalosporins.Ototoxicity induced by gentamicin and furosemide.Joining the DoTS: new approach to classifying adverse drug reactionsTransplacental passage of vancomycin in the ex vivo human perfusion model.Ceftaroline desensitization procedure in a pregnant patient with multiple drug allergies.Drug allergyGenetic aspects of immune-mediated adverse drug effects.Allergy to antibiotics in children: Perception versus reality.Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis.Clinical features and etiology of adult patients with Fever and rashGuideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients.The use of systemic antibiotics in the treatment of chronic wounds.Antibiotics and antifungals in neonatal intensive care units: a review.Adverse Drug Reactions Associated with Ceftaroline Use: A 2-Center Retrospective Cohort.The prevalence and reliability of self-reported penicillin allergy in a community hospital.Awareness of Iranian's General Dentists Regarding the Latest Prophylaxis Guideline for Prevention of Infective EndocarditisImmediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.Clinical immunology review series: an approach to desensitization.Desensitization regimens for drug allergy: state of the art in the 21st century.Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model.Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.Adverse reactions to β-lactam antimicrobials.Summary of ceftaroline fosamil clinical trial studies and clinical safety.Skin testing for Beta-lactam antibiotics: impact of the availability of a major determinant.Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Beta-lactam hypersensitivity and cross-reactivity.Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge.The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactionsThe 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.Update on the management of antibiotic allergyClarithromycin and pulmonary infiltration with eosinophilia.Possible cefotaxime-induced Stevens-Johnson syndrome.Investigation of serotype distribution and resistance genes profile in group B Streptococcus isolated from pregnant women: a Chinese multicenter cohort study.Cefazolin use in patients who report a non-IgE mediated penicillin allergy: a retrospective look at adverse reactions in arthroplasty.
P2860
Q24609834-AAE7E317-C54F-4F7A-8D7C-EC11D5046FE6Q28262781-09E2A6CB-DB96-414B-9BC0-E1238E10BBA5Q33893965-73D695BB-F316-4CD9-9259-34EE794C8E63Q34076784-BD8B2DF6-E36A-4B16-B724-13FF0C163120Q34236662-3EFFBE9F-42BC-4ED2-813F-C2A552C2813DQ34356777-618716D7-E283-4BAB-8026-3C3E746C5045Q34429676-9DFC0A92-EFC7-40B3-ACF2-170828A6D01EQ34521641-B24457B6-59F2-410D-93B0-647D8085CFA0Q35590133-E4F790DE-337B-45A5-987D-F6F6079F397EQ35614548-6802635A-50E9-4D59-A4BB-BA19E5C80B45Q35628320-4352A946-C554-4EF6-8647-B99013F1AC9EQ35632119-055910C8-3395-4584-8986-6CBF65FB3C77Q36028231-797BB2D4-3E0D-4A24-8490-B7C80CD3BAD8Q36170538-61EA7A23-4187-4BB1-A228-5ABD7C33AF48Q36332368-447660CA-8840-4DBF-B4D8-46DEFEB57675Q36421617-33AD4A70-011C-417F-9755-9B1CBABAB0FCQ36640891-59A99144-23F4-42FB-8C47-6E2CA48D34DFQ36697683-DBAD1770-02F2-4847-913A-1AC4A56A5D11Q36740036-8BCA5373-398A-4006-9C6B-20DBB5FCECA8Q37080538-35C7BC12-B98A-4BAC-B513-5EBA822B749DQ37378369-7DAA47AB-87DD-493D-86B6-708B651A4C96Q37590593-49794207-994E-41A7-8664-AAFED37A92ABQ37710230-4A151B8D-ED30-4225-A4F3-829AB99CDF0AQ37822834-1EF93F4E-4739-4896-B33B-9B953B706552Q37924898-123BBCAC-2E73-4432-BF0C-B25EF1DDB5C7Q37933361-53F2D170-E8BC-4438-BC05-E2445C530687Q37961946-9EC50014-9661-4B92-B797-0BFF1623B6EAQ37973385-0C17199F-4890-42AE-AF1B-BA9340C05F5EQ38035807-60320260-BC72-4C40-840B-FA53EBEC90D3Q38066759-B7C57D28-952C-4781-8717-CADC90A92751Q38185097-B3E94404-53CB-449C-9DF8-18B3B4387FA4Q38240001-70D095C7-F2C7-427B-B97C-9912A9979566Q38449671-80D70680-0481-4F89-BA2B-F42753CBF156Q38539645-524DCFC9-2602-4F84-8888-0E4597A09BA7Q38637036-4539031B-A945-4A30-9BFF-1B153CD44B77Q39830842-75F7A387-C4E7-4BE3-923F-957A3EA3F1BCQ40556499-39511C76-7354-4D53-A48C-B8EAF6710BEEQ40558171-CA84CB20-856B-48A2-8260-C27DD7B6477FQ40601705-E98F977B-518C-4E3C-840F-110714C20043Q42097346-23CE1767-8974-4682-AC98-72E2C6C23479
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cephalosporin allergy.
@ast
Cephalosporin allergy.
@en
Cephalosporin allergy.
@nl
type
label
Cephalosporin allergy.
@ast
Cephalosporin allergy.
@en
Cephalosporin allergy.
@nl
prefLabel
Cephalosporin allergy.
@ast
Cephalosporin allergy.
@en
Cephalosporin allergy.
@nl
P356
P1476
Cephalosporin allergy.
@en
P304
P356
10.1056/NEJMRA993637
P407
P577
2001-09-01T00:00:00Z